The US Food and Drug Administration clearedWithings’ ScanWatch smartwatch to detect atrial fibrillation and measure blood oxygen, the Issy-les-Moulineaux, France-based company announced on 12 October.
Other wearable devices marketed to consumers, including the Apple Watch, can measure blood-oxygen saturation (SpO2) and have FDA-cleared electrocardiogram (ECG) functions, but Withings is touting ScanWatch as the first wrist-worn device to simultaneously receive FDA clearance for
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?